πŸ‡ΊπŸ‡Έ FDA
Patent

US 11566078

PDL1-binding proteins

granted A61PA61P29/00A61P35/00

Quick answer

US patent 11566078 (PDL1-binding proteins) held by Inhibrx, Inc. expires Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Inhibrx, Inc.
Grant date
Tue Jan 31 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 26 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61P, A61P29/00, A61P35/00, A61P37/04, A61P43/00